Plenary 1– Global Trends in Biotech Industry (A)
Date: 22 July (Wednesday) 09:00 – 10:30 (GMT+8)
Venue: 701EF, 7F, TaiNEX2 / Online event platform
David has devoted more than 30 years to developing information products for biotechnology executives and investors.
David is a member of the Advisory Board of the Innovation and New Ventures Office (INVO) at Northwestern University and a member of the Advisory Council of the Keck Graduate Institute of the Applied Life Sciences. He also has served as a member of the Stanford Graduate School of Business Management Board.
In 1996, David and BioCentury Co-Founder & Chairman Karen Bernstein were honored with the Special Recognition Award given by the annual gathering of biotechnology chief executive officers in Laguna Niguel, Calif., citing BioCentury's ongoing contributions to the industry.
David is a graduate of the University of California at Berkeley and holds an MBA from Stanford University.
Speech title & Synopsis
Despite the COVID-19 crisis, the most favored biotechs continue to attract large amounts of money. What do these biotech “money magnets” have in common? And what have investors identified as their hot spots going forward? In this keynote, BioCentury CEO David Flores identifies the characteristics of the money magnets in today’s market and points out where biotechs and their investors face special challenges going into 2021.